Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 2/20 | 0.34 |
| ▸ | KDM1A | O60341 | 4/20 | 0.32 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29924699 | 0.89 | FPR2 (0.34) | FPR2KDM1AKCNH2CYP2D6CYP2C19 | |
| SCHEMBL30085768 | 0.83 | KDM4E (0.38) | FPR2KDM1AACHEHRH3KCNH2 | |
| SCHEMBL30085699 | 0.83 | HRH3 (0.39) | FPR2KDM1AHRH3KCNH2 | |
| SCHEMBL30085708 | 0.81 | HRH3 (0.37) | FPR2KDM1AHRH3KCNH2CYP2D6 | |
| SCHEMBL30085724 | 0.79 | HRH3 (0.36) | FPR2KDM1AHRH3 | |
| SCHEMBL29924650 | 0.78 | FPR2 (0.36) | FPR2KDM1AHRH3 | |
| SCHEMBL29925063 | 0.77 | CD274 (0.37) | FPR2KDM1AHRH3KCNH2CYP2D6 | |
| SCHEMBL29924990 | 0.76 | ADRA1D (0.33) | FPR2KDM1AHRH3 | |
| SCHEMBL30085771 | 0.75 | KDM1A (0.38) | FPR2KDM1AACHEHRH3KCNH2 | |
| SCHEMBL29925527 | 0.75 | KDM1A (0.33) | FPR2KDM1AACHEHRH3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4274569-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | Anima Biotech Inc. (US) | 2023-11-15 | — | — | EP | disclosed |
| WO-2022150316-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2022-07-14 | — | — | WO | disclosed |